Starpharma Holdings Limited (SPL) is a biotechnology company engaged in the development of dendrimer products for pharmaceutical, life science and other applications. Activities within the Company are directed towards the development of precisely defined nano-scale materials, with a particular focus on the development of its topical vaginal microbicide VivaGel for the treatment and prevention of bacterial vaginosis (BV), as a condom coating, and prevention of genital herpes and human immunodeficiency virus (HIV), and the application of dendrimers to drug delivery and other life science applications. Through partners, it is exploring dendrimer opportunities in materials science with applications in areas such as cosmetics, agrochemicals, and coatings.Starpharma has three core development programs: VivaGel portfolio, drug delivery and agrochemicals with the Company developing a number of products internally and others via commercial partnerships.